GlassScriptPhysician profile
Vikash Khurana
NPI 1649341025
$6,172.14
in general payments reported to CMS, 2019-2025
36 companies · $644 in 2025
The $644 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $81.01 · 2021: $203 · 2022: $2,851 · 2023: $594 · 2024: $1,532 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,246 · Travel and Lodging: $428 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,245.97 |
| Travel and Lodging | $428.09 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,552.58 | 2022-2024 | Turbohawk, Closurefast |
| Actelion Pharmaceuticals US, INC. | $625.03 | 2019-2025 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $442.52 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $392.59 | 2019-2025 | Farxiga, Brilinta, Fasenra |
| Amgen INC. | $359.84 | 2019-2025 | Repatha, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.50 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $214.81 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $165.00 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $145.28 | 2024-2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.55 | 2019-2024 | Lifevest |
| Abiomed | $92.51 | 2024-2025 | Impella |
| Shockwave Medical, INC | $74.70 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $67.33 | 2024 | Arcalyst |
| Philips North America LLC | $62.89 | 2019-2025 | Coronary Other |
| Bayer Healthcare Pharmaceuticals INC. | $56.59 | 2023-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $55.62 | 2019-2024 | |
| Genzyme Corporation | $54.42 | 2022-2024 | |
| Abbott Laboratories | $47.84 | 2023 | Xience Skypoint, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $44.66 | 2025 | Eliquis, Camzyos |
| United Therapeutics Corporation | $41.23 | 2024-2025 | Tyvaso, Tyvaso |
| Terumo Medical Corporation | $37.53 | 2022 | |
| Pulmonx Corporation | $32.08 | 2019 | |
| Acist Medical Systems, INC. | $27.13 | 2024 | |
| Glaxosmithkline, LLC. | $25.50 | 2021-2024 | Nucala |
| Amarin Pharma, INC. | $25.34 | 2019-2021 | |
| Grifols USA, LLC | $22.37 | 2019-2020 | |
| Mylan Specialty L.P. | $19.48 | 2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $18.41 | 2024 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $17.37 | 2025 | Glassia |
| Resmed Corp | $17.17 | 2022 | |
| Preventice Services, LLC | $16.87 | 2019 | |
| Inspire Medical Systems, INC. | $13.86 | 2025 | Inspire |
| Chiesi USA, INC. | $13.42 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.18 | 2022 | |
| Baxter Healthcare | $13.14 | 2023 | Hillrom - Life 2000 Ventilation System |
| Sunovion Pharmaceuticals INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikash Khurana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.